Asian Phytoceuticals PCL 2021 IR
The report highlights Asian Phytoceuticals Public Company Limited's (APCO) performance and operations for the fiscal year 2021. During the year, the company announced the success of its Operation BIM research team in developing a plant-based innovative immunotherapy to help HIV-infected patients achieve undetectable virus levels without antiretroviral drugs. APCO also launched MYLIFE100, a longevity innovation formula designed to lengthen telomeres and improve quality of life. Financially, the company recorded total sales revenue of 223.35 million Baht and a net profit of 68.70 million Baht, representing a net profit margin of 28.72%. Additionally, APCO maintained its commitment to sustainability by aligning with the UN Sustainable Development Goals and following GRI Standards.
Company: Asian Phytoceuticals PCL
Sector: Manufacturing
Country: Thailand
Year: 2021
Type: IR
Pages: 186
Back to company
Asian Phytoceuticals PCL
Annual Registration Statement / Annual Report
The report highlights Asian Phytoceuticals Public Company Limited's (APCO) performance and operations for the fiscal year 2021. During the year, the company announced the success of its Operation BIM research team in developing a plant-based innovative immunotherapy to help HIV-infected patients achieve undetectable virus levels without antiretroviral drugs. APCO also launched MYLIFE100, a longevity innovation formula designed to lengthen telomeres and improve quality of life. Financially, the company recorded total sales revenue of 223.35 million Baht and a net profit of 68.70 million Baht, representing a net profit margin of 28.72%. Additionally, APCO maintained its commitment to sustainability by aligning with the UN Sustainable Development Goals and following GRI Standards.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees